Therapy-related myelodysplastic syndromes
- PMID: 1613013
Therapy-related myelodysplastic syndromes
Abstract
This article summarizes the clinical aspects, cytogenetics, and initiating agents associated with therapy-related myelodysplastic syndromes. Details regarding associated chemotherapeutic agents and ionizing radiation are discussed and therapeutic considerations are presented.
Similar articles
-
[Etiological factors of myelodysplastic syndromes].Pathol Biol (Paris). 1997 Sep;45(7):539-44. Pathol Biol (Paris). 1997. PMID: 9404476 Review. French.
-
Therapy-related myelodysplastic syndromes.Semin Hematol. 1996 Jul;33(3):256-73. Semin Hematol. 1996. PMID: 8819235 Review. No abstract available.
-
Secondary myelodysplastic syndromes and leukaemias.Clin Haematol. 1986 Nov;15(4):1037-80. Clin Haematol. 1986. PMID: 3552347 Review.
-
Therapy-related leukemia and myelodysplastic syndrome.Semin Oncol. 1987 Dec;14(4):435-43. Semin Oncol. 1987. PMID: 3321448 Review. No abstract available.
-
Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.In Vivo. 1994 Nov-Dec;8(5):807-18. In Vivo. 1994. PMID: 7727729 Review.
Cited by
-
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.Bone Marrow Transplant. 2012 Jun;47(6):804-9. doi: 10.1038/bmt.2011.180. Epub 2011 Sep 12. Bone Marrow Transplant. 2012. PMID: 21909142 Free PMC article. Clinical Trial.
-
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.Blood. 2023 May 11;141(19):2359-2371. doi: 10.1182/blood.2022018244. Blood. 2023. PMID: 36626250 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical